För läkare

 
 
  Start > Om depression > Psykoterapi > Referenser
   Vad är psykoterapi?
   Psykologiskt
   omhändertagande
   Psykoterapi, läkemedel
   eller både och?
   Etiologiska hypoteser
   Kan alla med depressions-
   sjukdom gå i psykoterapi?
   Hur verksam är
   psykoterapi?
   Tidsperspektivet
   När bör man ompröva en
   psykoterapi som inte har
   hjälpt?
   Kan psykoterapi förebygga
   nya depressioner?
   Olika psykoterapier
   Grupp eller familjeterapi?
   Kognitiv beteendeterapi
   (KBT)
   Interpersonell psykoterapi
   (IPT)
   Psykodynamisk
   insiktsterapi
   Riskbedömning
   Psykoterapiernas roll
   sammanfattat
   Kostnader
   Referenser
Referenser
 
1 Bower P, Byford S, Sibbald B, Ward E, King M, Lloyd M, Gabbay M. Randomised controlled trial of non-directive counselling, cognitive-behaviour therapy, and usual general practitioner care for patients with depression. II: cost effectiveness. BMJ. 2000 Dec 2;321(7273):1362-3 (Fulltext av artikeln)
2 Bowlby J, The making and breaking of affectional bonds. I. Aetiology and psychopathology in the light of attachment theory. An expanded version of the Fiftieth Maudsley Lecture, delivered before the Royal College of Psychiatrists, 19 November 1976. Br J Psychiatry 1977 Mar;130:201-10
3 Bowlby J, The making and breaking of affectional bonds. II. Some principles of psychotherapy. The fiftieth Maudsley Lecture. Br J Psychiatry 1977 May;130:421-31
4 Clarkin JF, et. al. Psychotherapy of depression, implication for reform of the health system, Arch Gen Psychiatry 1996 Aug;53(8):717-23
5 de Jonghe F, Kool S, van Aalst G, et al. Combining psychotherapy and antidepressants in the treatment of depression. J Affect Dis 2001 May; 64:217-229
6 DeRubeis et al. Medications versus cognitive behavior therapy for severly depressed outpatients. Am J Psychiatry 1999;156:1007-1013.
7 Dewan M. Are psychiatrists cost-effective? An analysis of integrated versus split treatment. Am J Psychiatry 1999;156:324-326.
8 Edgell ET, Hylan TR, Draugalis JR, Coons SJ. Initial treatment choice in depression: impact on medical expenditures. Pharmacoeconomics 2000 Apr;17(4):371-82
9,10 Goldman W, McCulloch J, Cuffel B, et al. Outpatient utilization patterns of integrated and splitpsychotherapy and pharmacotherapy for depression. Psychiatr Serv 1998;49:477-482.
   
11 Guthrie E, Moorey J, Margison F, et al. Cost-effectiveness of brief psychodynamic-interpersonal therapy in high utilizers of psychiatric services. Arch Gen Psychiat 1999;56:519-526.
12 Keller MB, McCullough JP, Klein DN, Arnow B, Dunner DL, Gelenberg AJ, Markowitz JC, Nemeroff CB, Russell JM, Thase ME, Trivedi MH, Zajecka J.A Comparison of nefazodone, the cognitive behavioral-analysis system of psychotherapy, and their combination for the treatment of chronic depression. N Engl J Med. 2000 May 18;342(20):1462-70.
13 Lurie SN. Placebo effects and antidepressant medication. Implications for research and clinical care. Bull Menninger Clin 1996;60:94-101.
14 Miller IW, Norman WH, Keitner GI. Combined treatment for patients with double depression. Psychother Psychosom. 1999;68(4):180-5.
15 Ogles BM, Lambert MJ, Sawyer D. The clinical significans of the NIMH treatment of depression collaborative research, 1993. As quoted in Lambert MJ, Bergin AE. The effectivenss of psychotherapy. In Bergin AE, Garfield SL.(eds.) Handbook of psychotherapy and behavior change. 4th edition. New York,NY: John Wiley & sons, 1994:179.
16 Paykel ES Psychotherapy, medication combinations, and compliance. J Clin Psychiatry 1995;56 Suppl 1:24-30
18 Persons JB, Thase ME, Crits-Christoph P The role of psychotherapy in the treatment of depression: review of two practice guidelines. Arch Gen Psychiatry 1996;53:283-90
19 Reynolds CF, Frank E, Perel JM, et al. Nortriptyline and interpersonal psychotherapy as maintenance therapies for recurrent major depression. JAMA 1999;281:39-45.
20 Reynolds CF, Miller MD, Pasternak, RE, et al. Treatment of bereavement-related major depressive episodes in later life. Am J Psychiatry 1999;156:202-208.
21 Rothbaum BO, Astin MC. Integration of pharmacotherapy and psychotherapy for bipolar disorder. J Clin Psychiatry 2000; 61 Suppl 9:68-75
22 Teasdale JD et. al., Prevention of relapse/recurrence in major depression by mindfulness-based cognitive therapy, Consult Clin Psychol 2000 Aug;68(4):615-23
23 The Royal College of Psychiatrists: Physical brain function changes after successful psychotherapy for depression Press Release, Friday 2 July 1999. jmf:The Times, Why it’s good to talk to a therapist’ by Susie Steiner – July 1, 1999 och The Times, Psychotherapy: old treatment with new-found effects’ by Phillip Helding – July 28, 1999.
24 Shea MT, Elkin I, Imber SD, et al. Course of depressive symptoms over follow-up. Findings from the National Institute of Mental Health Treatment of Depression Collaborative Research Program. Arch Gen Psychiatry 1992;49:782-7.
25 Thase ME When are psychotherapy and pharmacotherapy combinations the treatment of choice for major depressive disorder?
Psychiatr Q. 1999 Winter;70(4):333-46. Review.

Ytterligare läsning:
Rush AJ, Thase ME: Psychotherapies for depressive disorders: A review. With commentaries by Myrna M Weissman, Bruce E Wampold,John C Markowitz, T. Byram Karasu, Carlo Perris, John S McIntyre, Robert Michels, Christoph Mundt, Giovanni A Fava, Raymondo Macías, and John C Nemiah. In: Maj M, Sartorius N (eds.) Depressive disorders. Chichester: John Wiley & sons, 1999:161-232.
 
Länkar:
www.riksforeningenpsykoterapicentrum.se/
www.st-lukas.se/
www.kognitiva.org/

Senast uppdaterad: 2001-11-27

 
 
  
 

 
  © Organon AB 2006 - Fiskhamnsgatan 6A, 414 58 Göteborg, telefon 031-720 65 00, fax 031-720 65 01
  Om deprimerad.net | webmaster@organon.se | www.organon.se